Serum Talin-1 and Cripto-1 in Colorectal Cancer
ConditionColo-rectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The goals of this study are
* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls. * To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age >18 years Old.
Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction)
Patients diagnosed with colorectal cancer by imaging and histopathology
Disqualifiers
Age <18 years old.
Patients with past history of chemotherapy or surgical excision of tumor
Patients with familial adenomatous polyposis
Patients with hereditary non-polyposis colorectal cancer
Trial design
Design model
Single group
Treatments tested in this trial
Serum level of Human Talin-1
Diagnostic testTo evaluate the clinical utility of Talin-1 measurement in colorectal cancer patients in comparison with healthy controls.
Serum level of Human Cripto-1
Diagnostic testTo evaluate the clinical utility of Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.
Treatment groups
70 Participants
are divided into 1 treatment groupGroup A: Group(1)Experimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
Serum Talin-1 measurement in colorectal cancer patients
measuring serum level of talin-1 in colorectal cancer patient to compare its level with healthy control
Time frame
From enrollment up to one weekSecondary outcomes
1
Serum Cripto-1 measurement in colorectal cancer patients
Time frame
From enrollment up to one weekSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: